SRSF1 and central nervous system cancer: Nevertheless, we investigated both the role of SRSF1 as a potential poor prognostic factor in GBM patients and its oncogenic function through correlations with other predictors of glioma malignant behavior, including cell migration, blood vascular microvessel density (MVD) and autophagy.